Covered recipient · General Payments record
MICHAEL I MAITAR
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2019–2025
$3,247.08
- Reported across 36 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $881.11 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $246.52 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $218.53 | 2 |
| Janssen Biotech, Inc. | $135.36 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $132.44 | 1 |
| ABBVIE INC. | $123.26 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $123.26 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202351179 | CMS |
| Aimmune Therapeutics, Inc. | $125.00 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249663786 | CMS |
| Aimmune Therapeutics, Inc. | $93.53 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249663784 | CMS |
| Boston Scientific Corporation | $132.44 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181251886 | CMS |
| Janssen Biotech, Inc. | $109.38 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175457002 | CMS |
| Janssen Biotech, Inc. | $25.98 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175456932 | CMS |
| Novartis Pharmaceuticals Corporation | $25.00 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200599257 | CMS |
| Phathom Pharmaceuticals, Inc. | $123.26 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219295334 | CMS |
| Phathom Pharmaceuticals, Inc. | $123.26 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219356258 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.